Stephanie Krebs

Insider Reports History

Entity
Individual
Location
C/O Sensei Biotherapeutics, Inc., 1405 Research Blvd, Suite 125, Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie Krebs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 125K Nov 1, 2023 Direct

Insider Reports Filed by Stephanie Krebs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNSE Sensei Biotherapeutics, Inc. Nov 1, 2023 1 $0 4 Nov 2, 2023 Chief Business Officer
SNSE Sensei Biotherapeutics, Inc. Nov 1, 2023 0 $0 3 Nov 2, 2023 Chief Business Officer